BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34715539)

  • 1. Adequacy of Mediastinal Lymph Node Sampling in Patients With Lung Cancer Undergoing Lung Resection.
    Taylor M; Evison M; Clayton B; Grant SW; Martin GP; Shah R; Krysiak P; Rammohan K; Fontaine E; Joshi V; Granato F
    J Surg Res; 2022 Feb; 270():271-278. PubMed ID: 34715539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adequacy of Intraoperative Nodal Staging during Surgical Resection of NSCLC: Influencing Factors and Its Relationship to Survival.
    Edwards T; Balata H; Elshafi M; Foden P; Bishop P; Fontaine E; Jones M; Krysiak P; Rammohan K; Shah R; Crosbie P; Booton R; Evison M
    J Thorac Oncol; 2017 Dec; 12(12):1845-1850. PubMed ID: 28782727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Updated Commission on Cancer Guidelines for Intraoperative Lymph Node Sampling in Early Stage NSCLC.
    Heiden BT; Eaton DB; Chang SH; Yan Y; Schoen MW; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
    J Thorac Oncol; 2022 Nov; 17(11):1287-1296. PubMed ID: 36049657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node dissection and survival in patients with early stage nonsmall cell lung cancer: A 10-year cohort study.
    Shen-Tu Y; Mao F; Pan Y; Wang W; Zhang L; Zhang H; Cheng B; Guo H; Wang Z
    Medicine (Baltimore); 2017 Oct; 96(43):e8356. PubMed ID: 29069017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.
    Darling GE; Allen MS; Decker PA; Ballman K; Malthaner RA; Inculet RI; Jones DR; McKenna RJ; Landreneau RJ; Rusch VW; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):662-70. PubMed ID: 21335122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.
    Zheng H; Gao W; Fei K; Xie HK; Jiang GN; Ding JA; Li C; Chen C; Zhang L
    Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):447-54. PubMed ID: 23788199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical experience and patient-related restrictions predict the adequacy of cervical mediastinoscopy in non-small cell lung carcinoma lymph node staging.
    Klinkenberg TJ; Bouma W; Van De Wauwer C; Wolf RFE; Mariani MA; Groen HJM
    J Cardiothorac Surg; 2018 Dec; 13(1):134. PubMed ID: 30594219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer?
    David EA; Cooke DT; Chen Y; Nijar K; Canter RJ; Cress RD
    Ann Thorac Surg; 2017 Jan; 103(1):226-235. PubMed ID: 27469339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mediastinal lymph nodes sampling in patients with clinical stage I non-small cell lung cancer.
    Takizawa H; Kondo K; Matsuoka H; Uyama K; Toba H; Kenzaki K; Sakiyama S; Tangoku A; Miura K; Yoshizawa K; Morita J
    J Med Invest; 2008 Feb; 55(1-2):37-43. PubMed ID: 18319543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score.
    Ishiguro F; Matsuo K; Fukui T; Mori S; Hatooka S; Mitsudomi T
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):1001-6. PubMed ID: 19733863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non-Small Cell Lung Cancer.
    Smeltzer MP; Faris N; Yu X; Ramirez RA; Ramirez LE; Wang CG; Adair C; Berry A; Osarogiagbon RU
    Ann Thorac Surg; 2016 Aug; 102(2):448-53. PubMed ID: 27266421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
    Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
    J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer.
    Gajra A; Newman N; Gamble GP; Kohman LJ; Graziano SL
    J Clin Oncol; 2003 Mar; 21(6):1029-34. PubMed ID: 12637467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Completeness of lung cancer surgery: is mediastinal dissection common practice?
    Verhagen AF; Schoenmakers MC; Barendregt W; Smit H; van Boven WJ; Looijen M; van der Heijden EH; van Swieten HA
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):834-8. PubMed ID: 22290900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ; Han F; Gao SL; A DL; Pang ZL
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediastinal lymph node dissection versus mediastinal lymph node sampling for early stage non-small cell lung cancer: a systematic review and meta-analysis.
    Huang X; Wang J; Chen Q; Jiang J
    PLoS One; 2014; 9(10):e109979. PubMed ID: 25296033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.